11
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Re: "Letter to the Editor: Repurposing of an Antisepsis Drug in COVID-19 Patients," by Kumar et al.

      1
      Assay and drug development technologies
      Mary Ann Liebert Inc

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Assay Drug Dev Technol
          Assay and drug development technologies
          Mary Ann Liebert Inc
          1557-8127
          1540-658X
          Oct 2021
          : 19
          : 7
          Affiliations
          [1 ] Molecular Immunogenetics Group, National Institute of Immunology, New Delhi, India.
          Article
          10.1089/adt.2020.1002
          34463124
          90d1c46f-bf80-4cd6-a712-588c49f76227
          History

          Comments

          Comment on this article